Startups
PierianDx
Edit

PierianDx

https://www.pieriandx.com/
Last activity: 13.01.2023
Active
Categories: AnalyticsCareDataHealthTechITPlatformSaaSServiceSoftwareTechnology
PierianDx addresses the challenges of scalability and handling the complexity of larger gene sets by enabling clinical labs to streamline workflow and access a single, integrated space that provides a curated knowledgebase, comprehensive analysis, insightful interpretation, and precise reporting. This “one-space” solution is PierianDx’s Clinical Genomicist Workspace (CGW) – a complete suite of solution modules accompanied by support services that provide a data-driven ecosystem for clinical labs to launch or expand their NGS testing programs. PierianDx also provides a range of support services and programs to help healthcare organizations accelerate their Personalized Medicine programs and NGS testing initiatives, including: The PierianDx NGS Gateway Program allows clinical labs to access and customize a range of NGS assays right out of the box, providing a turnkey, virtual NGS lab weeks and; PierianDx’s Professional Services ensure that clinical labs have everything they need to effective.
Likes
9
Followers
9.62K
Website visits
37.1K /mo.
Mentions
21

Overview

Location
United States, Missouri, Creve Coeur
Employees
201-500
Phone
+1 314-626-8043
Total raised
$83.75M
Founded date
2014

Investors 7

Funding Rounds 3

DateSeriesAmountInvestors
Sign up to seeSign up to seeSign up to seeSign up to see
Oct 28, 2019Series B round$27M
Jan 7, 2016Series A round$9.25M

Mentions in press and media 21

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Dec 7, 2022Pierian Selected by PreCheck Health Services to Support Hereditary Cancer Testing for Providers and PatientsPierian, a global leader in advanced clinical genomics technology and services, announced a collaboration to support PreCheck Health Services, a CLIA-registered, CAP-accredited high complexity laboratory, in providing cancer-related genomic...
Nov 2, 2021PierianDx Closes up to $47.5 Million of Growth Capital
Nov 2, 2021PierianDx Closes up to $47.5 Million of Growth CapitalPierianDx, the global leader in clinical genomics knowledge, announced that it closed on $30 million of new growth capital including equity financing and a term loan facility, which includes access to additional tranches for up to $17.5 mil...
Mar 2, 2021PierianDx Announces the Appointment of Lindsay Mateo as Chief Business OfficerST. LOUIS--(BUSINESS WIRE)--Mar 2, 2021-- PierianDx, the global leader in clinical genomics knowledge, today announced the appointment of Lindsay Mateo as Chief Business Officer, effective immediately. In her new role, Ms. Mateo will reinfo...
Oct 28, 2019PierianDx raises $27M in Series B to ‘democratize’ next-generation sequencing“PierianDx has grown tremendously over the past 18 months and is continuing to add the clinical expertise and resources necessary to execute on our vision,” PierianDx Executive Chairman Rakesh Nagarajan said in a statement. “Our team is uni...
Oct 28, 2019PierianDx Closes $27M Series B FinancingPierianDx, a St. Louis-based clinical genomics informatics company, closed a $27m Series B funding round. The round was led by ATW Partners and SJF Ventures with participation from existing investors Health Catalyst Capital, Inova Health Sy...
Oct 17, 2017Cleveland Clinic Joins PierianDx’s Customer Network to Accelerate Precision MedicineST. LOUIS–(BUSINESS WIRE)–October 17, 2017– PierianDx announced today that Cleveland Clinic will utilize its integrated “one space” workflow and analysis solution, Clinical Genomicist Workspace (CGW), to advance precision medicine for patie...
Apr 6, 2017Intermountain Healthcare Innovation Fund gives some more love to RedoxHealthbox has previously run an accelerator for healthcare startups called Healthbox Studio but with the management change last year, Healthbox repositioned itself as a venture capital investment manager with an innovation platform that fun...
Mar 3, 2017PierianDx’s Partner Sharing Network Achieves Critical Mass with New Wave of Customers Adopting Clinical Genomicist Workspace (CGW)ST. LOUIS–(BUSINESS WIRE)–March 3, 2017– PierianDx announced today that six leading healthcare systems and academic medical centers have chosen its leading “One Space” genomics software solution, CGW, to streamline clinical lab workflow, an...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about PierianDx

When was PierianDx founded?

PierianDx was founded in 2014.

How much funding has PierianDx raised?

PierianDx has raised $83.75M in total across 3 funding rounds.

What funding rounds has PierianDx raised?

Parsers VC lists 3 funding rounds of PierianDx, among them a Series B round of $27M on Oct 28, 2019 and a Series A round of $9.25M on Jan 7, 2016.

Who has invested in PierianDx?

Parsers VC lists 7 investors of PierianDx, among them SJF Ventures, Health Catalyst Capital Management and ATW Partners.

What has the press written about PierianDx?

Parsers VC has collected 21 articles mentioning PierianDx, among them “Pierian Selected by PreCheck Health Services to Support Hereditary Cancer Testing for Providers and Patients” (Dec 7, 2022) and “PierianDx Closes up to $47.5 Million of Growth Capital” (Nov 2, 2021).

Is PierianDx still active?

Yes, PierianDx is active; its latest activity on Parsers VC dates from Jan 13, 2023.